About
Technology
Issues
FAQ
Links
Official Page
A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.